D Giakoumettis1,2, A Kritis3,4, N Foroglou2. 1. First Department of Neurosurgery, University of Athens Medical School, "Evangelismos" General Hospital, Athens. 2. First Department of Neurosurgery, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. 3. Laboratory of Physiology, Faculty of Medicine, School of Health Sciences. 4. cGMP Regenerative Medicine facility, Department of Physiology and Pharmacology, Faculty of Medicine, School of Health Sciences.
Abstract
BACKGROUND: Glioblastoma multiforme is the most aggressive brain tumor with poor prognosis and an average survival of 1-2 years. Animal models that simulate the features of human glioma are the key to newer agents or therapeutic strategies. In order to establish such models, the C6 glioma cell line has been mostly used in neuro-oncology research. METHODS: In this narrative review, we systematically reviewed the international literature in order to retrieve and present the most important biological and molecular features of C6 cell line. RESULTS: Even though many cell lines have been developed, each cell line presents with slight differences from human glioma behavior. C6 cancer cell line is a rat glioma cell line, which can simulate in overall the high growth rate, the high vascularization, and the highly infiltrative character of glioblastoma multiforme. CONCLUSIONS: Most of the C6 glioma research has been focused on testing a wide diversity of agents for their tumoricidal activity. C6 cell line is considered to be a safe and popular glioma model in the literature, providing a good simulation of glioblastoma multiforme. HIPPOKRATIA 2018, 22(3): 105-112. Copyright 2018, Hippokratio General Hospital of Thessaloniki.
BACKGROUND:Glioblastoma multiforme is the most aggressive brain tumor with poor prognosis and an average survival of 1-2 years. Animal models that simulate the features of humanglioma are the key to newer agents or therapeutic strategies. In order to establish such models, the C6 glioma cell line has been mostly used in neuro-oncology research. METHODS: In this narrative review, we systematically reviewed the international literature in order to retrieve and present the most important biological and molecular features of C6 cell line. RESULTS: Even though many cell lines have been developed, each cell line presents with slight differences from humanglioma behavior. C6cancer cell line is a ratglioma cell line, which can simulate in overall the high growth rate, the high vascularization, and the highly infiltrative character of glioblastoma multiforme. CONCLUSIONS: Most of the C6 glioma research has been focused on testing a wide diversity of agents for their tumoricidal activity. C6 cell line is considered to be a safe and popular glioma model in the literature, providing a good simulation of glioblastoma multiforme. HIPPOKRATIA 2018, 22(3): 105-112. Copyright 2018, Hippokratio General Hospital of Thessaloniki.
Entities:
Keywords:
C6; cell line; glioblastoma multiforme; glioma; rat glioma model
Authors: Maria Grazia Atzori; Lucio Tentori; Federica Ruffini; Claudia Ceci; Elena Bonanno; Manuel Scimeca; Pedro Miguel Lacal; Grazia Graziani Journal: J Pharmacol Exp Ther Date: 2017-10-12 Impact factor: 4.030
Authors: Deepti Singh; Pierre C Dromel; Tatiana Perepelkina; Petr Baranov; Michael Young Journal: Cell Transplant Date: 2020 Jan-Dec Impact factor: 4.064
Authors: Francesca Manni; Fons van der Sommen; Himar Fabelo; Svitlana Zinger; Caifeng Shan; Erik Edström; Adrian Elmi-Terander; Samuel Ortega; Gustavo Marrero Callicó; Peter H N de With Journal: Sensors (Basel) Date: 2020-12-05 Impact factor: 3.576
Authors: Tatiana I Terpinskaya; Alexey V Osipov; Elena V Kryukova; Denis S Kudryavtsev; Nina V Kopylova; Tatsiana L Yanchanka; Alena F Palukoshka; Elena A Gondarenko; Maxim N Zhmak; Victor I Tsetlin; Yuri N Utkin Journal: Mar Drugs Date: 2021-02-21 Impact factor: 5.118
Authors: Artemiy S Silantyev; Olga N Bukato; Ivan O Butenko; Anastasia A Chernysheva; Olga V Pobeguts; Alexander E Nosyrev; Olga I Gurina Journal: Data Brief Date: 2021-12-01